The Torbett Laboratory has three research areas: Evolution of HIV-1 inhibitor resistance and fitness; Hematopoietic stem and T cell gene delivery strategies to block HIV-1entry and limit infection; and The regulation of normal and abnormal myeloid development and function by the ets transcription factor PU.1 (spi). Please check the Research page for more information on our research program.
Recent Publication (Blood): Resveratrol trimer enhances gene delivery to hematopoietic stem cells by reducing antiviral restriction at endosomes
Press Release from Scripps Research: When added to gene therapy, plant-based compound may enable faster, more effective treatments